[1]宁明哲,陶 月,陈雨欣,等.新型冠状病毒血清特异性抗体检测的假性问题分析和对策探讨[J].现代检验医学杂志,2020,35(06):129-131.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]
 NING Ming-zhe,TAO Yue,CHEN Yu-xin,et al.SARS-CoV-2 Serological Antibody Testing: Problems of FalseDetections and the Solutions[J].Journal of Modern Laboratory Medicine,2020,35(06):129-131.[doi:doi:10.3969/j.issn.1671-7414.2020.06.031]
点击复制

新型冠状病毒血清特异性抗体检测的假性问题分析和对策探讨()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年06期
页码:
129-131
栏目:
新型冠状病毒肺炎检验专题
出版日期:
2020-12-30

文章信息/Info

Title:
SARS-CoV-2 Serological Antibody Testing: Problems of FalseDetections and the Solutions
文章编号:
1671-7414(2020)06-129-03
作者:
宁明哲 陶 月 陈雨欣 柏 兵
(南京大学医学院附属鼓楼医院检验科,南京 210008)
Author(s):
NING Ming-zhe TAO Yue CHEN Yu-xin BAI Bing
(Department of Laboratory Medicine, Gulou Hospital Affiliated to Medical College of Nanjing University,Nanjing 210008, China)
关键词:
新型冠状病毒肺炎新型冠状病毒IgM 抗体IgG 抗体假阳性假阴性
分类号:
R373.19;R446
DOI:
doi:10.3969/j.issn.1671-7414.2020.06.031
摘要:
新型冠状病毒肺炎对全球造成了巨大威胁。目前血清抗体检测,成为该疾病诊断和流行控制的关键指标。我国“新型冠状病毒肺炎诊疗方案(试行第七版)”中,已明确将新型冠状病毒抗体检测作为临床确诊标准。在临床实际工作过程中,笔者发现新型冠状病毒抗体检测存在着假阳性或者假阴性的问题,给临床解读造成困扰。该文针对新型冠状病毒抗体检测方法的设计和原理,分析可造成假阳性和假阴性结果的原因,并指出解决方法,从而促进对新冠病毒抗体检测更好的理解,以及为临床提供更加全面的结果解读。

参考文献/References:

[1] 华人民共和国国家卫生健康委员会 . 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL].(2020-03-4)
[2020-03-04].http//www.nhc.gov.cn/yzygj/s7653p/202003/ 46c9294a7dfe4cef80dc-7f5912eb1989.shtml.National Health Commission of the People’s Republicof China .The guideline of diagnosis and treatmentof COVID-19(Pilot Release 7)[EB/OL].(2020-03-4)
[2020-03-04].http//www.nhc.gov.cn/yzygj/s7653p/202003/ 46c9294a7dfe4cef80dc7f5912eb1989.shtml.
[2] MEYER B, DROSTEN C, MU LLER M A. Serologi-cal assays for emerging coronaviruses: challenges andpitfalls[J]. Virus Research, 2014, 194: 175-183.
[3] LU Hongzhou, STRATTON C W, TANG Yiwei. Out-break of pneumonia of unknown etiology in Wuhan,China: The mystery and the miracle[J]. Journal of Med-ical Virology, 2020, 92(4):401-402.
[4] 鲁彦,居军,李德红.核酸和血清学指标结合 , 多类型标本联检 , 提高新型冠状病毒检出率 [J/OL]. 检验医学与临床 , 2020, 17(9): 1161-1163, 1165.LU Yan,JU Jun,LI Dehong. Novelcoronavirusdetection rate is improved by combining nucleicacid and serological markers with multiple types ofspecimens[J/OL].Laboratory Medicine and Clinic,2020,17(9):1161-1163, 1165.
[5] 王露莹,陈品儒,郑国湾,等.新型冠状病毒检测方法的研究进展 [J/OL].现代药物与临床 , 2020,35(3): 411-416.WANG Luying,CHEN Pinru,ZHENG Guowan,etal. Research progress on detection methods of SARS-CoV-2 [J/OL]. Drugs & Clinic, 2020, 35(3): 411-416.
[6] GRIFONI A, SIDNEY J, ZHANG Yun, et al. ASequence homology and bioinformatic approach canpredict candidate targets for immune responses toSARS-CoV-2[J]. Cell Host & Microbe, 2020, 27(4):671-680,e2.
[7] LU Roujian, ZHAO Xiang, LI Juan, et al. Genomiccharacterisation and epidemiology of 2019 novelcoronavirus:implications for virus origins and receptorbinding[J]. The Lancet, 2020, 395(10224):565-574.
[8] REES A R. Understanding the human antibodyrepertoire[J]. MAbs, 2020, 12(1): 1729683.
[9] 上海市医学会检验医学分会 . 新型冠状病毒核酸和抗体检测临床应用专家共识 [J/OL]. 国际检验医学杂志,2020,41(14):1665-1669.Shanghai Medical Association Laboratory MedicineBranch. Consensus of novel coronavirus nucleic acidand antibody detection for clinical application[J/OL]. International Journal of Laboratory Medicine ,2020,41(14):1665-1669.
[10] 郑培明,崔发财,张福明 , 等.新型冠状病毒 IgM 和IgG 抗体不同检测方法在新型冠状病毒感染中的临床应用评价 [J]. 检验医学 , 2020, 35(4):291-294.ZHENG Peiming, CUI Facai, ZHANG Fuming,et al. Clinical evaluation of different detection meth-ods of SARS-CoV-2 IgM and IgG antibodies in theCOVID-19 diagnosis[J]. Laboratory Medicine, 2020,35(4):291-294.

相似文献/References:

[1]童 伟,陈登奕,陈俊文,等.2019-nCoV 总抗体两种免疫学检测方法的应用评价[J].现代检验医学杂志,2020,35(02):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
 TONG Wei,CHEN Deng-yi,CHEN Jun-wen,et al.Application Evaluation of Two Immunological Detection Methodsof 2019-nCoV Specific Antibodies[J].Journal of Modern Laboratory Medicine,2020,35(06):80.[doi:10.3969/j.issn.1671-7414.2020.02.023]
[2]谢 辉,刘玮玮b,郭 娟a,等.新型冠状病毒肺炎疫情下检验医学临床服务管理的探索[J].现代检验医学杂志,2020,35(03):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
 XIE Huia,LIU Wei-weib,GUO Juana,et al.Exploration on Clinical Service Management of Laboratory Medicine during COVID-19 Epidemic Period[J].Journal of Modern Laboratory Medicine,2020,35(06):81.[doi:10.3969/j.issn.1671-7414.2020.03.020]
[3]陈泽衍,马 雯,张立俊,等.荧光免疫层析法检测全血2019-nCoV IgM 和IgG 抗体在新型冠状病毒肺炎诊断中的应用[J].现代检验医学杂志,2020,35(03):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
 CHEN Ze-yan,MA Wen,ZHANG Li-jun,et al.Application of 2019-nCoV IgM and IgG Tests by Fluorescence Immunochromatography in the Diagnosis of 2019-nCoV Infections[J].Journal of Modern Laboratory Medicine,2020,35(06):84.[doi:10.3969/j.issn.1671-7414.2020.03.021]
[4]朱传新,周玉平,何 艳,等.92 例新冠肺炎病毒感染患者早期外周血白细胞形态分析[J].现代检验医学杂志,2020,35(03):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
 ZHU Chuan-xin,ZHOU Yu-ping,HE Yan,et al.Morphological Analysis of Early Peripheral Blood Leukocytes in 92 Patients with New Coronary Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(06):94.[doi:10.3969/j.issn.1671-7414.2020.03.024]
[5]刘艳霞,区静怡,黄 颖,等.新型冠状病毒肺炎患者外周血淋巴细胞及其亚群检测的临床意义[J].现代检验医学杂志,2020,35(04):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
 LIU Yan-xia,OU Jing-yi,HUANG Ying,et al.Clinical Significance of Detection of Peripheral Blood Lymphocyte and Its Subgroups in Patients with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(06):94.[doi:10.3969/j.issn.1671-7414.2020.04.023]
[6]佟 丽,黄丽萍,石晓霞,等.血栓弹力图检测新型冠状病毒肺炎患者凝血功能的探讨分析[J].现代检验医学杂志,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
 TONG Li,HUANG Li-ping,SHI Xiao-xia,et al.Investigation and Analysis of Thromboelastography in the Detection of COVID-19 Patients[J].Journal of Modern Laboratory Medicine,2020,35(06):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
[7]胡纪文,王恩运,阚丽娟,等.三种化学发光法检测新型冠状病毒(SARS-CoV-2)抗体试剂盒的临床应用评价[J].现代检验医学杂志,2020,35(04):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
 HU Ji-wen,WANG En-yun,KAN Li-juan,et al.Evaluation of Clinical Application of Three Chemiluminescence Detection Kits for Detection of Novel Coronavirus (SARS-CoV-2) Antibody[J].Journal of Modern Laboratory Medicine,2020,35(06):100.[doi:10.3969/j.issn.1671-7414.2020.04.025]
[8]白欢,沈玲,袁旭,等.新型冠状病毒肺炎患者早期外周血实验室检查结果分析[J].现代检验医学杂志,2020,35(05):93.[doi:10.3969/j.issn.1671-7414.2020.05.024]
 BAI Huan,SHEN Ling,YUAN Xu,et al.Analysis of the Characteristics of Hematological Parameters in the Early Stages of COVID-19[J].Journal of Modern Laboratory Medicine,2020,35(06):93.[doi:10.3969/j.issn.1671-7414.2020.05.024]
[9]闫美田,郑雨桐,孙艳美,等.新型冠状病毒肺炎患者血液CRP, CREA, ALB, IL-6 水平检测对疾病预后的应用价值分析[J].现代检验医学杂志,2020,35(05):106.[doi:10.3969/j.issn.1671-7414.2020.05.027]
 YAN Mei-tian,ZHENG Yu-tong,SUN Yan-mei,et al.Analysis of the Value of Detection of Blood CRP,CREA,ALB and IL-6 Level in Patients with New Coronavirus Pneumonia to the Prognosis of the Disease[J].Journal of Modern Laboratory Medicine,2020,35(06):106.[doi:10.3969/j.issn.1671-7414.2020.05.027]
[10]王琳琳a,张晓凝,王刚b,等.外周血白细胞参数对于新型冠状病毒肺炎诊断的临床意义[J].现代检验医学杂志,2020,35(05):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]
 WANG Lin-lina,ZHANG Xiao-ning,WANG Gangb,et al.Clinical Significance of Peripheral Blood Leukocyte Parameters in the Diagnosis of COVID-19[J].Journal of Modern Laboratory Medicine,2020,35(06):110.[doi:10.3969/j.issn.1671-7414.2020.05.028]
[11]朱旭阳,叶寒青,陈文亥,等.新型冠状病毒肺炎患者血清SARS-CoV-2 抗体的检测分析[J].现代检验医学杂志,2020,35(04):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]
 ZHU Xu-yang,YE Han-qing,CHEN Wen-hai,et al.Preliminary Analysis of Serum Antibodies Against SARS-CoV-2 in Patient with Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2020,35(06):106.[doi:10.3969/j.issn.1671-7414.2020.04.026]
[12]张园,周泽奇,王志贤,等.新型冠状病毒核酸、抗原和抗体联合检测的临床价值讨论[J].现代检验医学杂志,2020,35(05):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
 ZHANG Yuan,ZHOU Ze-qi,WANG Zhi-xian,et al.Discussion on the Clinical Value of Combined Detection of SARS-CoV-2 Nucleic Acid,Antigen and Antibody[J].Journal of Modern Laboratory Medicine,2020,35(06):99.[doi:10.3969/j.issn.1671-7414.2020.05.025]
[13]陈赛,刘海艇,李铁,等.新型冠状病毒肺炎患者肝功能异常的相关临床分析[J].现代检验医学杂志,2020,35(05):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
 CHEN Sai,LIU Hai-ting,LI Tie,et al.Clinical Analysis of Abnormal Liver Function in Patients with New Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2020,35(06):103.[doi:10.3969/j.issn.1671-7414.2020.05.026]
[14]孟凡萍,郝 坡.新型冠状病毒肺炎患者外周血淋巴细胞亚群的分析研究[J].现代检验医学杂志,2021,36(02):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
 MENG Fan-ping,HAO Po.Analysis of Peripheral Blood Lymphocyte Subsets in Patients with Novel Coronavirus Pneumonia[J].Journal of Modern Laboratory Medicine,2021,36(06):114.[doi:doi:10.3969/j.issn.1671-7414.2021.02.027]
[15]吴永彬,李 凌.CRISPR/Cas系统在新型冠状病毒肺炎快速诊断中的应用[J].现代检验医学杂志,2022,37(03):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]
 WU Yong-bin,LI Ling.Application of CRISPR/Cas Systems in the Rapid Diagnosis of Coronavirus Disease 2019[J].Journal of Modern Laboratory Medicine,2022,37(06):1.[doi:10.3969/j.issn.1671-7414.2022.03.001]

更新日期/Last Update: 2020-12-20